Spineguard (France) Executives
| ALSGD Stock | EUR 0.20 0.01 4.76% |
Spineguard employs about 21 people. The company is managed by 6 executives with a total tenure of roughly 42 years, averaging almost 7.0 years of service per executive, having 3.5 employees per reported executive. Discussion of Spineguard's management performance can provide insight into the enterprise performance.
| Steve McAdoo President Vice President - Business Development, Member of the Management Board |
Spineguard |
Spineguard Management Team Effectiveness
The company has return on total asset (ROA) of (0.082) % which means that it has lost $0.082 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.4335) %, meaning that it generated substantial loss on money invested by shareholders. Spineguard's management efficiency ratios could be used to measure how well Spineguard manages its routine affairs as well as how well it operates its assets and liabilities.Spineguard Workforce Comparison
Spineguard is number one stock in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 118,039. Spineguard adds roughly 21.0 in number of employees claiming only tiny portion of equities under Health Care industry.
The company has Profit Margin (PM) of (0.44) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.33) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.33. Spineguard Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Spineguard Price Series Summation is a cross summation of Spineguard price series and its benchmark/peer.
Spineguard Notable Stakeholders
A Spineguard stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Spineguard often face trade-offs trying to please all of them. Spineguard's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Spineguard's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Steve McAdoo | Vice President - Business Development, Member of the Management Board | Profile | |
| Manuel Lanfossi | CFO, Member of the Management Board, IR Contact Officer | Profile | |
| Maurice Bourlion | CoInventor Director | Profile | |
| Patricia Lempereur | Director of Marketing & Training, International, Member of the Management Board | Profile | |
| Pierreme | Chairman CoFounder | Profile | |
| Stphane Bette | Deputy CoFounder | Profile |
About Spineguard Management Performance
The success or failure of an entity such as Spineguard often depends on how effective the management is. Spineguard management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Spineguard management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Spineguard management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
The companys PediGuard products are handheld devices that detect possible vertebral cortex perforation during pedicle preparation for screw placement, and alerts surgeons prior to a breach by analyzing the electrical conductivity of the surrounding tissues in real time. SpineGuard SA was founded in 2009 and is headquartered in Vincennes, France. SPINEGUARD operates under Medical Devices classification in France and is traded on Paris Stock Exchange. It employs 19 people.
Spineguard Workforce Analysis
Traditionally, organizations such as Spineguard use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Spineguard within its industry.Spineguard Manpower Efficiency
Return on Spineguard Manpower
| Revenue Per Employee | 209.8K | |
| Revenue Per Executive | 734.2K | |
| Net Loss Per Employee | 82.1K | |
| Net Loss Per Executive | 287.5K |
Additional Tools for Spineguard Stock Analysis
When running Spineguard's price analysis, check to measure Spineguard's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spineguard is operating at the current time. Most of Spineguard's value examination focuses on studying past and present price action to predict the probability of Spineguard's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spineguard's price. Additionally, you may evaluate how the addition of Spineguard to your portfolios can decrease your overall portfolio volatility.